Read a little. Learn a lot. • Tightly-written news, views and stuff • Follow us on Twitter • Be a Facebook Fan • Tumble us!
 

Posted on June 1, 2009 | tags

 
 

Biz: An acquisition pays off in the form of a landmark cancer drug

  • $500 million The amount French drugmaker Sanofi-Aventis SA paid for BiPar Sciences Inc. of San Francisco, which has just 18 employees source

Posted by Ernie Smith • Permalink